Metlife Inc. diskutieren

MetLife, Inc. (NYSE: MET) had its price target lowered by analysts at Piper Sandler from $85.00 to $82.00. They now have an "overweight" rating on the stock.

MetLife, Inc. (NYSE: MET) had its price target lowered by analysts at Keefe, Bruyette & Woods from $87.00 to $86.00. They now have an "outperform" rating on the stock.

MetLife, Inc. (NYSE: MET) had its price target lowered by analysts at Wells Fargo & Company from $86.00 to $85.00. They now have an "overweight" rating on the stock.

MetLife, Inc. (NYSE: MET) had its price target raised by analysts at Argus from $77.00 to $80.00. They now have a "buy" rating on the stock.

MetLife, Inc. (NYSE: MET) had its price target lowered by analysts at Jefferies Financial Group Inc. from $88.00 to $83.00. They now have a "buy" rating on the stock.

MetLife, Inc. (NYSE: MET) had its price target raised by analysts at JPMorgan Chase & Co. from $81.00 to $86.00. They now have an "overweight" rating on the stock.

MetLife, Inc. (NYSE: MET) had its price target lowered by analysts at Keefe, Bruyette & Woods from $86.00 to $85.00. They now have an "outperform" rating on the stock.

MetLife, Inc. (NYSE: MET) had its price target raised by analysts at Morgan Stanley from $82.00 to $83.00. They now have an "overweight" rating on the stock.

MetLife, Inc. (NYSE: MET) had its price target raised by analysts at Citigroup Inc. from $83.00 to $89.00. They now have a "buy" rating on the stock.

MetLife, Inc. (NYSE: MET) had its price target lowered by analysts at Bank of America Co. from $99.00 to $96.00. They now have a "buy" rating on the stock.

MetLife, Inc. (NYSE: MET) had its price target raised by analysts at Wells Fargo & Company from $85.00 to $86.00. They now have an "overweight" rating on the stock.

MetLife, Inc. (NYSE: MET) had its price target lowered by analysts at Morgan Stanley from $86.00 to $85.00. They now have an "overweight" rating on the stock.

MetLife, Inc. (NYSE: MET) had its price target raised by analysts at Jefferies Financial Group Inc. from $89.00 to $95.00. They now have a "buy" rating on the stock.

MetLife, Inc. (NYSE: MET) had its price target raised by analysts at Piper Sandler from $85.00 to $92.00. They now have an "overweight" rating on the stock.

MetLife, Inc. (NYSE: MET) is now covered by analysts at TD Cowen. They set a "buy" rating and a $97.00 price target on the stock.

MetLife, Inc. (NYSE: MET) had its price target raised by analysts at Wells Fargo & Company from $86.00 to $92.00. They now have an "overweight" rating on the stock.

Hey there! I've been digging into MetLife (MET) lately, and I've got to say, I'm pretty impressed. This insurance giant seems to be on solid footing, and here's why I'm leaning towards a buy: First off, let's talk dividends. MET's currently offering a juicy 2.59% yield, which is nothing to sneeze at in this market. They've been consistently growing their dividend too, with a 5.8% increase from last year. It's like they're handing out bigger slices of the pie every year! But it's not just about the dividends. The company's earnings are looking strong, with analysts expecting a 17.33% growth in EPS for 2024. That's like MetLife is hitting the gym and bulking up its financial muscles! What really caught my eye, though, is their global strategy. They're expanding their reach for globally-mobile employees, which is a smart move in our increasingly connected world. It's like they're casting a wider net to catch more fish, you know? On top of that, MetLife's getting some love for their inclusion efforts. They've been recognized by Seramount for their diverse workplace culture. It's not just good PR - diverse companies often perform better in the long run. Oh, and let's not forget about their pension risk transfer business. With more companies looking to offload pension liabilities, MetLife's positioned to capitalize on this trend. It's like they've found a golden ticket in a shifting market landscape. Sure, there are always risks in the insurance biz, especially with market volatility and changing interest rates. But MetLife seems to be navigating these waters pretty well. All in all, I'm feeling bullish about MetLife. With their strong fundamentals, growth potential, and strategic positioning, I think they could see some nice upside. That's why I'm eyeing a target price of $85.50. Remember though, this is just my take - always do your own research before making any investment decisions!

MetLife, Inc. (NYSE: MET) had its price target lowered by analysts at Barclays PLC from $91.00 to $90.00. They now have an "overweight" rating on the stock.

MetLife, Inc. (NYSE: MET) had its price target raised by analysts at Wells Fargo & Company from $92.00 to $93.00. They now have an "overweight" rating on the stock.

MetLife, Inc. (NYSE: MET) had its price target raised by analysts at TD Cowen from $97.00 to $99.00. They now have a "buy" rating on the stock.